Search Results - Angelo Avogaro
- Showing 1 - 20 results of 43
- Go to Next Page
-
1
Mechanisms of cardiovascular protection of non-insulin antidiabetic medications by Angelo Avogaro
Published 2018-11-01
Article -
2
How to interpret the role of SDF-1α on diabetic complications during therapy with DPP-4 inhibitors by Gian Paolo Fadini, Angelo Avogaro
Published 2018-02-01
Article -
3
Diabetic retinopathy: a tool for cardiovascular risk stratification by Angelo Avogaro, Gian Paolo Fadini
Published 2019-12-01
Article -
4
La gestione del paziente diabetico tra presente e futuro by Angelo Avogaro, Antonio C. Bossi
Published 2017-10-01
Article -
5
-
6
Efficacy of telemedicine for persons with type 1 diabetes during Covid19 lockdown by Federico Boscari, Sara Ferretto, Ambra Uliana, Angelo Avogaro, Daniela Bruttomesso
Published 2021-01-01
Article -
7
-
8
-
9
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-co... by Benedetta Maria Bonora, Saula Vigili de Kreutzenberg, Angelo Avogaro, Gian Paolo Fadini
Published 2019-08-01
Article -
10
-
11
-
12
-
13
-
14
-
15
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study by Enrico Longato, Barbara Di Camillo, Giovanni Sparacino, Lara Tramontan, Angelo Avogaro, Gian Paolo Fadini
Published 2021-11-01
Article -
16
-
17
-
18
-
19
Cholesterol lowering therapies and achievement of targets for primary and secondary cardiovascular prevention in type 2 diabetes: unmet needs in a large population of outpatients a... by Mario Luca Morieri, Angelo Avogaro, Gian Paolo Fadini, the DARWIN-T2D Network of the Italian Diabetes Society
Published 2020-11-01
Article -
20